Lipoprotein (a) as a predictor of myocardial infarction in middle-aged men

American Journal of Medicine

Volumn 110, Issue 1, 2001, Pages 22-27

  Seed, Mary ^a   Ayres, Karen L ^b   Humphries, Steve E ^d   Miller, George J ^c  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; LIPOPROTEIN A; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; AGE; ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SUDDEN DEATH; UNITED KINGDOM;

EID: 0035182721     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00652-5     Document Type: Article

References (39)

1. Myocardial ischaemia, risk factors and death from coronary heart disease
2. Risk factors for ischaemic heart disease: The prospective phase of the British Regional Heart Study
3. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
4. Apolipoproteins and ischaemic heart disease: Implications for screening
5. Lipoprotein (a) and atherosclerosis
6. Lipoprotein (a). Thrombogenesis linked to atherogenesis at last?
7. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen
8. A potential basis for the thrombotic risks associated with lipoprotein (a)
9. Antifibrinolytic activity of lipoprotein (a) in vivo: Human apolipoprotein (a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis
10. Catabolism of lipoprotein (a) in normal and familial hypercholesterolaemic subjects
11. The mysteries of lipoprotein (a)
12. Apolipoprotein (a) gene accounts for greater than 90% of the variation in plasma lipoprotein (a) concentrations
13. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys
14. Methods for the measurement of lipoprotein(a) in the clinical laboratory
15. Myocardial infarction community registers
16. Lipoprotein (a) and coronary heart disease: A prospective case-control study in a general population sample of middle aged men
17. Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol, and other risk factors: Results from the prospective Gottingen Risk Incidence and Prevalence Study (GRIPS)
18. Hypertriglyceridaemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged men
19. Is lipoprotein (a)-cholesterol a better predictor of vascular disease events than total lipoprotein (a) mass? A nested case control study from the West of Scotland Coronary Prevention Study
20. Lipoprotein (a) and coronary heart disease risk: A nested case-control study of the Helsinki Heart Study participants
21. A prospective study of lipoprotein (a) and the risk of myocardial infarction
22. Lipoprotein (a) in stored plasma samples and the ravages of time
23. Is lipoprotein (a) an independent risk factor for ischaemic heart disease in men?
24. Lipoprotein (a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: Results from the NHLBI Family Heart Study
25. Effects of lowering elevated low density lipoprotein cholesterol on the cardiovascular risk of lipoprotein (a)
26. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study
27. Lipoprotein (a) levels and risk of coronary heart disease in men
28. Elevated plasma lipoprotein (a) and coronary heart disease in men aged 55 years and younger
29. A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women: The Framingham Heart Study
30. 1-lipoprotein in patients with coronary heart disease
31. Apolipoprotein (a), AI, and B and parental history in men with early onset ischaemic heart disease
32. Lipoprotein (a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes
33. Occlusive arterial thrombosis in cynomologus monkeys with varying plasma concentrations of lipoprotein (a)
34. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis
35. Proteoglycans' contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix
36. Estrogen and progestin, lipoprotein (a) and the risk of recurrent coronary heart disease events after menopause